Healthcare organizations can now connect Epic to ChatGPT — OpenAI shipped an Epic connector plus a nine-source Healthcare Public Data plugin (PubMed, DailyMed, CMS Coverage, ClinicalTrials.gov, RxNorm and more) on Sept 1, with seven launch partners including UCSF Health, Cedars-Sinai, Memorial Sloan Kettering and HCA. The connection is read-only — OpenAI’s word is “currently.” 🔮 My bet: write access ships within 18 months, scoped to one non-clinical field — a chart-prep note, a documentation gap — because that’s the smallest object a health system can govern.
Vision Pro scrubbed in at Duke — Stryker announced Sept 1 that SportSuite Vision, De Novo-authorized July 17, completed its first live case: a hip arthroscopy by Chad Mather III, MD, MBA (a paid Stryker consultant).
The AMA hired DiMe’s founder to run its AI center — Jennifer Goldsack, founder and CEO of the Digital Medicine Society, is SVP of the AMA’s Center for Digital Health and AI, first named leader since the center launched in October 2025.
🎧 Podcast: Lifers — “Price in healthcare is market share, not quality” — Garner Health founder and CEO Nick Reber’s flat claim: price tracks market share, not outcomes — “the price is totally unrelated to quality, just totally unrelated.”
🧭 The Curbside
“Can I use Google’s new forecasting model for census and vitals?”
Short answer: You can prototype with it today. You probably cannot ship it.
What changed: TimesFM-3 landed Aug 31 — 330M parameters, natively multivariate, zero-shot. It forecasts related series jointly and accepts known future events as inputs. No fine-tuning, no ML team.
Builder read / watchout: The weights are public but carry the TimesFM Non-Commercial License v1.0 — no revenue-generating use, no production systems, no redistribution. (The GitHub code is still Apache-2.0; it’s the 3.0 checkpoint that’s restricted.) Prototype on synthetic or public census data, prove the lift, then either license it or fall back to TimesFM-2.5, which is still the commercially usable version and already runs in BigQuery.
😤 “Zero-shot forecasting on physiologic data is a fantasy.” Partly. It won’t beat a purpose-built model on a well-characterized series. But most of us don’t have a purpose-built model — we have a spreadsheet and a hunch. Nothing to calibrated baseline in an afternoon isn’t nothing.
🔬 The Big Thing
The tool that finally reached the chart is the one that promised not to touch it.
OpenAI announced Sept 1 that health systems can connect their Epic environments to ChatGPT for Healthcare, with seven launch partners — UCSF Health, Cedars-Sinai, Memorial Sloan Kettering, HCA Healthcare, AdventHealth, Baylor Scott & White and Boston Children’s.
Clinicians can pull authorized patient context in — review a history, ask what changed since the last visit, prep for clinic. In supported deployments it integrates directly into the EHR layout, so you never leave the patient chart.
Here’s the part that isn’t in the announcement blog at all. It’s in the setup documentation: “The connection is currently read-only. It cannot update medical records, place orders, message patients, or override existing patient-chart permissions.” Every OAuth scope OpenAI publishes for the integration ends in .read.
Be precise about what that does and doesn’t mean. ChatGPT will happily draft your prior auth letter or your discharge instructions — those are workspace features. It just can’t file any of it back into Epic. A human moves it, or it doesn’t move.
Read-only is not a limitation they ran out of time to fix. It’s the product decision that made shipping possible.
⁉️ The public-data plugin is the quieter half. PubMed, DailyMed and CMS Coverage sitting in the same workspace as the chart means will this be paid for? is now one prompt from the clinical question. Nobody put that in a headline.
😤 “This is a wrapper. Epic ships its own assistant.” Sure. And the wrapper rides a general model that improves every eight weeks without an EHR release cycle. That’s the trade.
😤 “Read-only means it can’t do anything useful.” Ask a hospitalist how long they spend reconstructing what happened between admissions. Reading is most of the job.
😤 “Launch partners are just logos.” Seven of them, and Epic itself has said nothing — no statement, no comment in any of the day-one coverage. Which leaves open whether this is a sanctioned partnership or the standard third-party interface any developer can request. Worth watching.
❓ If read-only is the fast lane, what’s the most valuable thing a tool can do without ever writing?
📡 Builder’s Radar
Vision Pro scrubbed in — six weeks after authorization.
Stryker’s SportSuite Vision got FDA De Novo authorization July 17 and announced Sept 1 that it had completed its first live case at Duke Health — an FAI and labral repair hip arthroscopy, with four streams (arthroscopic video, HipCheck, HipMap and CT imaging) in the surgeon’s field of view. The labeling is careful: it’s a video see-through AR headset meant to be used in conjunction with the OR’s traditional monitors, not to replace them. The surgeon, Chad Mather III, MD, MBA, is a paid Stryker consultant.
🔮 My bet: the durable use isn’t the OR.
⚡ Quick hits
Dr. Gigi Magan’s “The 50 Million Questions” — a rejected 2020 AI fetal-monitoring proposal, Epic’s Physician Builder program, a bilingual cardiovascular-risk prototype. The most honest clinician-to-builder account I’ve read this month.
LeanTaaS acquired Aidin — inpatient flow optimization and post-acute discharge referral in one stack. The discharge bottleneck, finally treated as a data problem.
UNC lands up to $35M for a rare disease AI resource — an ARPA-H award under its RAPID program, co-led with Emory over four and a half years, building the data substrate for AI-driven rare disease diagnosis.
🎙️ From the Pods
🎙️ Lifers with Christina Farr — “Price in healthcare is market share, not quality”
Garner Health’s Nick Reber: what sets price is market share — “how big of an oligopoly or a monopoly has the hospital system been able to create” — and quality has nothing to do with it. “No one’s ever seen a correlation.” His build advice was blunter: every job family is moving toward code, so the differentiating skill is the production layer nobody demos — Git, how databases actually work, not putting your security credentials in the repo.
💡 Builder take: The prototype isn’t the hard part anymore. Ship the boring hygiene on day one or the working demo is unshippable.
🔇 Speaker Blindspot: Goodhart’s law, never raised. He mentions health systems using Garner’s data to set physician compensation as straightforward upside — better care, more recommended volume. But the cheapest way to improve a complication rate isn’t better surgery, it’s declining the complex patient. Neither he nor Farr brings it up. He does note that complication rates vary 4x between the top and bottom quartile at brand-name hospitals adjusted for patient population — which is the right instinct, just not applied to the incentive he’s creating.
🎙️ HIMSSCast — “Intel presents: Orchestrating outcomes: The real role of AI in cancer care”
Alex Flores, GM of Intel’s health and life sciences vertical, on why oncology AI stalls: “AI and cancer care won’t scale on models alone. It’s going to scale when the infrastructure is ready and when compute, data security, and workflow integration come together at the clinical edge.” Adoption dies at the context switch — if the clinician has to go to a different screen or a different application, “often time that disruption prevents that solution from actually scaling.”
💡 Builder take: “What output, at what moment, in which screen” is the product decision. The model is the easy part.
🔇 Speaker Blindspot: Transparency, defined away. Flores spends the segment on oversight and then says “oftentimes, the clinician or the physician may not even know that the solution is running in the background, but that transparency is important.” You cannot supervise what you don’t know is running. Neither he nor Siemens Healthineers’ Peter Shen catches it.
💡 BTW
💡 BTW: Jennifer Goldsack, the AMA’s new AI center lead, rowed the lightweight double sculls for the United States at the 2008 Beijing Olympics, finishing 10th — having raced for the British national team in 2005 and 2006 before switching. Born in Wimbledon, she picked up rowing at Oxford after playing rugby there, while reading chemistry.
You have a unique combination of skills, experience and values. So do great things! … and tell me about them at kevin@clinicians.build.
— Kevin & AI
(please verify content for yourself, partially AI generated and may contain errors)